Related keylists
Sichuan Kelun Pharmaceutical Co Ltd (Kelun), a subsidiary of Sichuan Kelun Industrial Group Co Ltd, is a pharmaceutical company. It carries out the manufacturing and distribution of pharmaceutical products and medical devices. It offers various products including sodium chloride injection, mannitol injection, fructose and sodium chloride injection, dexmedetomidine injection, sugammadex sodium injections and others. Kelun also provides products such as apixaban tablets, fudosteine tablets, olanzapine tablets, disposable nebulizer sets, sterile disposable injection syringes and disposable vein detained needles. The company also carries out research and development of pharmaceutical products. Kelun is headquartered in Chengdu, Sichuan, China.
Headquarters
China
Address
No.36, Baihua West Road, Qingyang District, Chengdu, Sichuan, 610071
Website
www.kelun.com
Telephone
86 28 82860516
No of Employees
18,422
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
002422 (SHE)
Revenue (2021)
$2.8B
9.5%
(2021 vs 2020)
EPS
XYZ
Net Income (2021)
XYZ
55%
(2021 vs 2020)
Market Cap*
$6.6B
Net Profit Margin (2021)
XYZ
41.5%
(2021 vs 2020)
* As of and is in US$
Sichuan Kelun Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Infusion Products | Uniflex |
| OTC Products | |
| Medical Devices | |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Plans/Strategy | In June, Sichuan Kelun-Biotech announced its plans to build international commercialization and global clinical development capabilities in the medium to long term. |
| 2022 | Contracts/Agreements | In December, Kelun-Biotech entered into an agreement with Merck to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer. |
| 2022 | Contracts/Agreements | In July, the company's subsidiary Kelun-Biotech entered into a license agreement with MSD to develop an investigational antibody drug conjugate for the treatment of solid tumors. |
Competitor Comparison
| Key Parameters | Sichuan Kelun Pharmaceutical Co Ltd | Yunnan Baiyao Group Co Ltd | CSPC Pharmaceutical Group Ltd | Shandong Xinhua Pharmaceutical Co Ltd | Yifan Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Chengdu | Kunming | Shijiazhuang | Zibo | Hangzhou |
| State/Province | Sichuan | Yunnan | Hebei | Shandong | Zhejiang |
| No. of Employees | 18,422 | 8,834 | 23,500 | 7,104 | 4,338 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Liu Genxin | Chairman | Executive Board | 2003 | 72 |
| Liu Sichuan | Managing Director; General Manager | Executive Board | 2015 | 39 |
| Lai Degui | Deputy General Manager; Chief Financial Officer | Senior Management | 2014 | 52 |
| Fan Wendi | Deputy General Manager | Senior Management | - | 41 |
| Ge Tao | Deputy General Manager | Senior Management | 2015 | 43 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward